FINDRISC (Finnish Diabetes Risk Score)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low0–3
- Low4–8
- Moderate9–12
- High13–20
The FINDRISC (Finnish Diabetes Risk Score) calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include age. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Identifies patients at high risk for type 2 diabetes within 10 years without the need for laboratory tests
Clinical Indication
The FINDRISC (Finnish Diabetes Risk Score) is indicated for bedside clinical practice to support Identifies patients at high risk for type 2 diabetes within 10 years without the need for laboratory tests. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Sum of points based on: Age (0-4 points) + BMI (0-3 points) + Waist circumference (0-4 points) + Physical activity (0-2 points) + Fruit/vegetable consumption (0-1 point) + Blood pressure medication (0-2 points) + High blood glucose history (0-5 points) + Family diabetes history (0-5 points)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | string | Yes | Patient age category |
| bmi | string | Yes | Body Mass Index category |
| waist_circumference | string | Yes | Waist circumference category |
| gender | string | Yes | Patient gender (needed for waist circumference evaluation) |
| physical_activity | string | Yes | Physical activity at least 30 minutes per day or ≥4 hours per week |
| fruit_vegetable_consumption | string | Yes | Daily consumption of fruits, vegetables, or berries |
| blood_pressure_medication | string | Yes | History of antihypertensive medication |
| high_blood_glucose_history | string | Yes | History of high blood glucose (e.g., during health examination, illness, or pregnancy) |
| family_diabetes_history | string | Yes | Family history of diabetes |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | Very Low | Very low risk |
| 4–8 | Low | Low risk |
| 9–12 | Moderate | Moderate risk |
| 13–20 | High | High risk |
| 21–26 | Very High | Very high risk |
Evidence-Based References (EBM)
- Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 Mar;26(3):725-31. doi: 10.2337/diacare.26.3.725.DOI: 10.2337/diacare.26.3.725
- Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005 May;2(2):67-72. doi: 10.3132/dvdr.2005.011.DOI: 10.3132/dvdr.2005.011
- Tankova T, Chakarova N, Atanassova I, Dakovska L. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011 Apr;92(1):46-52. doi: 10.1016/j.diabres.2010.12.020.DOI: 10.1016/j.diabres.2010.12.020